CMTM3 and ovarian cancer: Therefore, the abnormally high expression of CMTM3/5 and other family members was related to prognostic-related clinical characteristics and can affect the overall survival and progression-free survival of patients with ovarian cancer, indicating that it can be used as an influencing factor for the prognosis of patients with ovarian cancer.